Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pembrolizumab in addition to chemotherapy for advanced or metastatic urothelial cancer - first line Pembrolizumab (Keytruda; MK-3475) Urothelial cancer Urological Cancer 2018 View  |  Download
Pembrolizumab for Stage IV Colorectal Carcinoma – first line Pembrolizumab (Keytruda; MK-3475) Colorectal cancer Gastrointestinal Cancer , Oncology 2018 View  |  Download
Pembrolizumab for Advanced Hepatocellular Carcinoma – second line onwards Pembrolizumab (Keytruda; MK-3475) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2018 View  |  Download
Pembrolizumab (Keytruda) for relapsed/refractory classical Hodgkin lymphoma Pembrolizumab (Keytruda; MK-3475) Hodgkin lymphoma Haematological Cancer and Lymphomas 2018 View  |  Download
PEGPH20 in addition to Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Ductal Adenocarcinoma Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , Pegvorhyaluronidase alfa (PEGPH20) Pancreatic cancer Gastrointestinal Cancer 2018 View  |  Download
Pegargiminase in addition to pemetrexed and cisplatin for advanced malignant pleural mesothelioma – first line Cisplatin (Platinol) , Pegargiminase (ADI-PEG 20) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Malignant pleural mesothelioma (MPM) Lung and Respiratory Cancer 2018 View  |  Download
Oral Semaglutide for the treatment of type 2 diabetes mellitus Semaglutide (Ozempic) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Oleogel-S10 for Inherited Epidermolysis Bullosa Oleogel-S10 (Episalvan) Inherited epidermolysis bullosa (EB) Dermatology , Genetic Disorders 2018 View  |  Download
Olaparib for Metastatic Pancreatic Cancer with gBRCA Mutation Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Pancreatic cancer Gastrointestinal Cancer 2018 View  |  Download
Nivolumab in combination with ipilimumab in addition to chemotherapy for treating non-small cell lung cancer – first line Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2018 View  |  Download
1 2 4 5 6 7 8 14 15
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications